Adial Pharmaceuticals, Inc. (AZR) stock
AZRNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ADIL
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q/A on Oct 21, 2026Score 5/30
Share price
Not available yet
Price, market cap and P/E appear here once daily prices are connected.
Adial Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Adial Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$11.13M. For fiscal 2025 it was -$6.49M. The highest annual figure on record is -$494.86K in fiscal 2017.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$6.49M | – |
| FY2024 | Dec 31, 2024 | -$6.92M | – |
| FY2023 | Dec 31, 2023 | -$6.81M | – |
| FY2022 | Dec 31, 2022 | -$11.19M | – |
| FY2021 | Dec 31, 2021 | -$11.95M | – |
| FY2020 | Dec 31, 2020 | -$7.63M | – |
| FY2019 | Dec 31, 2019 | -$6.34M | – |
| FY2018 | Dec 31, 2018 | -$2.50M | – |
| FY2017 | Dec 31, 2017 | -$494.86K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$6.36M | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.61M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.32M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.83M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.75M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.59M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.45M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.69M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.15M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.63M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.22M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.39M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.89M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.30M | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.75M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.40M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.53M | – |
| Q1 FY2022 | Mar 31, 2022 | -$2.50M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.37M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.53M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.20M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.84M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.61M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.21M | – |
| Q2 FY2020 | Jun 30, 2020 | -$985.17K | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.83M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.75M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.72M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.14M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.72M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.10M | – |
| Q3 FY2018 | Sep 30, 2018 | -$991.25K | – |
| Q2 FY2018 | Jun 30, 2018 | -$188.94K | – |
| Q1 FY2018 | Mar 31, 2018 | -$214.28K | – |
| Q4 FY2017 | Dec 31, 2017 | -$122.10K | – |
| Q3 FY2017 | Sep 30, 2017 | -$136.78K | – |